1. F. Sulser, “Regulation and function of noradrenaline receptor systems in brain,” Neuropharmacology, 23, No. 3, 255–261 (1984).
2. G. R. Heninger and D. S. Charney, “Mechanisms of action of antidepressant treatments: implications for the etiology and treatment of depressive disorders,” in: Psychopharmacology: the Third Generation of Progress, H. Y. Meltzer (ed.), Raven Press, New York (1987), pp. 535–544.
3. S. Nishizawa, C. Benkelfat, S. N. Young, et al., “Differences between males and females in rates of serotonin synthesis in human brain,” Proc. Natl. Acad. Sci. USA, 94, No. 10, 5308–5315 (1997).
4. M. Baudry, M. P. Martes, and J. C. Schwartz, “Modulation in the sensitivity of noradrenergic receptors in the CNS studied by the cyclic AMP system,” Brain Res., 116, No. 1, 111–124 (1976).
5. C. Mazer, J. Muneyyirci, K. Taheny, et al., “Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits,” Brain Res., 760, No. 3, 760–768 (1997).